Skip to content

Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM

Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04246788
Acronym
RIPHIGEO
Enrollment
40
Registered
2020-01-29
Start date
2020-07-17
Completion date
2021-11-24
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Hemiplegia

Keywords

Infantile hemiplegia, Cerebral palsy, Intensive robotic rehabilitation

Brief summary

Cerebral palsy is the most frequent motor deficiency in children. Among other, it can leads to spastic diplegia or hemiplegia. Walking abilities is an important skill to the families' point of view in term of independence in curent life. Improving the walking parameters has been the main objective in several studies of rehabilitation. The G-EO system is a last generation robot assisting gait training that can adjust cadence, walk lengh, ankle and hip angles and other walking parameters to movement captation. Its superiority in terms of walking abilities has been demonstrated in adults with stroke sequelae. Only one study was realized in pediatric patients with spastic diplegia with promising results. The investigators hypothesize that intensive robot-assited gait training using the G-EO system in hemiplegic children can improve their walking abilities.

Detailed description

Objective : Primary objective: To evaluate walking velocity with the GRAIL (gait real-time analysis and interactive lab) after intensive robot-assisted gait training using the G-EO system in hemiplegic children. Secondary objectives :Other parameters that will be evaluate include: * Endurance on the 6 minute walking test * Joint angles and muscular contraction on the GRAIL * Number of steps and travelled distance /24h, cardiac frequency and quality of sleep using actimeter bracelet * Motor functions using the GMFM (Gross Motor Function Measure) * Spasticity using the modified Ashworth scale * The functional independence using the Functional Independence Measure (FIM™) for children, * The quality of life using the Patient Global Impression (PGI-I) * Muscular strength using the muscular testing cotation scale * The musculo-squeletal and adipose composition using the peripherical quantitative computed tomography (pQCT) * The cerebral area activation using functional MRI Study Type: Controlled randomized pilote study Number of centres: Monocentric study, University hospital of Clermont-Ferrand Study procedure: * Experimental group: 5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks * Control group : 3 sessions per week of 30 minutes of classical physiotherapy during two weeks Study evaluation: T0 : before rehabilitation : * Actimeter for 24h * 6 min walking test * GRAIL * Modified Ashworth scale * FIM for children * GMFM * Muscular testing scale * pQCT * fMRI T1 : one month after rehabilitation : * idem T0 * PGI-I questionnary Principal judgement criteria: Walking velocity Secondary judgement criteria: endurance, joint angles, number of steps and travelled distance per 24h, quality of sleep, cardiac frequency, spasticity, functional independence, motor functions, muscular strength, musculo-squeletal and adipose composition, brain activated areas. Number of subjects: * 20 patients in the experimental group * 20 patients in the control group All patients enrolled in the control group will benefit of the GEOsystem rehabilitation at the end of the protocole Inclusion criteria: Hemiplegic children aged from 4 to 18 years, with a GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement. Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program. Non inclusion criteria: No lower limb involvement, spasticity = 4 on the modified Ashworth scale, severe cardiorespiratory disease forbidding the rehabilitation program, orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study. Study calendar: * Starting inclusions: March 2020 * Experimental procedure: March 2020 to March 2021 * Data analyses and synthesis: April 2021 to Dember 2021 Statistical analyses Statistical analysis will be performed using Stata 13 software (Stata-Corp, College Station, TX) by an experimented statistician (Bruno Pereira) working in the university hospital of Clermont-Ferrand. A type-I error set at α=0.05 will be considered. Monovariate and multivariate analyses considering age as a covariable will be performed. Ethical considerations This study has already been presented at the local ethical committee and will be presented in July 2019 at the national " comité de protection des personnes ". Written informed consent from both parents will be collected at the inclusion. This study will be in agreement with the declaration of Helsinki and the current regulations of clinical trials. It will be declared on the internet site "clinicaltrials.gov". Expected results : Intensive robot-assisted gait training using the G-EO system may improve the walking abilities in children with infantile hemiplegia and consequently improve their independence and quality of life. Musculo-squeletal parameters and profile of cerebral activated areas involved in praxia may also be modified by this intensive rehabilitation.

Interventions

OTHERIntensive robotic rehabilitation

5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks

3 sessions per week of 30 minutes of classical physiotherapy during two weeks

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER
Université d'Auvergne
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Hemiplegic children aged from 4 to 18 years * GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement. * Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program. * Free and informed consent of holders of parental authority and of the patient * Affiliated to the social security system

Exclusion criteria

* No lower limb involvement, * spasticity = 4 on the modified Ashworth scale, * severe cardiorespiratory disease forbidding the rehabilitation program, * orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.

Design outcomes

Primary

MeasureTime frameDescription
Gait speedday 1gait speed assessed during a gait assessment session using the GRAIL system

Secondary

MeasureTime frameDescription
6 min. walk test (6-WT)day 1endurance evaluation by 6 min. walk test (6-WT)
joint anglesday 1Joint amplitudes measured during gait assessment with the GRAIL
number of steps per 24hday 1Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
travelled distanceday 1distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
quality of sleep: wristband actimeterday 1quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
cardiac frequencyday 1heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Evaluation of spasticityday 1Evaluation of spasticity by the modified Ashworth scale
functional independenceday 1Overall functional independence assessed with the MIF-Môme autonomy scale
motor functionsday 1Overall motor function evaluated with the EMFG
muscular strengthday 1Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Body composition measurementsday 21fat body mass
brain activated areasday 21Functional brain connectivity analyzes by functional brain MRI

Countries

France

Contacts

PRINCIPAL_INVESTIGATORCatherine Sarret

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026